JPRN-UMIN000007297尚未招募4 期
Combination therapy with amlodipine or trichlormetiazide added irbesartan in hypertensive patients with diabetes - Combination therapy with amlodipine or trichlormetiazide added irbesartan in hypertensive patients with diabetes
Control of organ function, Kanazawa University Hospital0 个研究点目标入组 120 人开始时间: 2012年2月15日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Hypersensitivity to or contraindication of irbesartan,trichlometiazide and amlodipine 2)within 3 months after onset of acute myocardial infarction 3)Symptomatic (NYHA3or4)congestive heart failure 4)Severe renal dysfunction or severe liver dysfunction 5)Pregnancy or its possibility 6) subjects whose doctor in charge do not agree to join the trial patients judged as inappropriate for the sutudy
研究者
相似试验
已完成
不适用
Combination therapy with azelnidipine or trichlormethiazide added on olmesartan in hypertensive patients with glucose intoleranceHypertension with glucose intoleranceJPRN-UMIN000003459Kanazawa Medical University Diabetes & Endocrinology40
已完成
不适用
Effect of combination therapy with amlodipine and atorvastatin on blood pressure varaiability, vascular function and renal function in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD stage 1-4)JPRN-UMIN000009045Yokohama city university hospital50
尚未招募
3 期
se of medicines- Hydroxyurea and thalidomide for children suffering from thalassemiaCTRI/2023/12/060945ICMR, Delhi
已完成
不适用
Practical combination therapy of Amlodin and angiotensin II Receptor blocker(ARB); safety and efficacy in paTieNts with hypERtension Study (PARTNER Study)HypertensionJPRN-UMIN000005888Dainippon Sumitomo Pharma Co.,Ltd.6,000
招募中
不适用
Palmitoylethanolamide as adjunctive treatment of Autism: A double blind and placebo controlled trialChildhood autism.Childhood autismIRCT201702171556N96Tehran University of Medical Sciences50